Global Antihypertensive Drugs Market to Reach US$ 38.0 Billion by 2032, Driven by the Increasing Prevalence of Hypertension

May 31, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Antihypertensive Drugs Market Report by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, and Others), Type (Primary Hypertension, Secondary Hypertension), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Commerce), and Region 2024-2032,” the global antihypertensive drugs market size reached US$ 29.7 Billion in 2023. Antihypertensive drugs, also known as antihypertensives, are medications used to treat high blood pressure, a condition known as hypertension. Hypertension is a chronic condition characterized by consistently elevated blood pressure levels, which can lead to significant health complications if left untreated. Antihypertensive drugs can be used alone or in combination to achieve optimal blood pressure control. They are effective in managing hypertension, along with lifestyle modifications, such as adopting a healthy diet, regular exercise, weight management, and stress reduction, are also crucial for long-term control of blood pressure. Regular monitoring and follow-up visits with healthcare professionals are necessary to assess the effectiveness of the medication and make any necessary adjustments to the treatment plan. Antihypertensive drugs work by targeting various mechanisms in the body to reduce blood pressure and help manage the condition. There are several classes of antihypertensive drugs available, each with its unique mode of action. These classes include diuretics, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, and renin inhibitors. These medications are prescribed based on factors, such as the severity of hypertension, individual patient characteristics, and the presence of other health conditions.


Global Antihypertensive Drugs Market Trends:

The increasing screening programs and early detection of hypertension represents one of the significant factors driving the growth of the market across the globe. This is primarily attributed to the rising awareness regarding hypertension and its potential health risks, which is driving the market growth. The market is also driven by the rising incidences of hypertension due to sedentary lifestyles, poor dietary choices, and high-stress levels. Apart from this, the increasing number of cases of diabetes, kidney diseases, obstructive sleep apnea, and other cardiovascular diseases, which are widely considered as the primary causes of hypertension, is driving the growth of the market. In line with this, the steadily expanding geriatric population base is further contributing to the growth of the market. In addition to this, the expiration of patents for specific antihypertensive drugs has led to the introduction of generic versions, resulting in increased market competition and affordability, thereby facilitating the growth of the market. Other factors, including advancements in medical technology and drug delivery systems improving the effectiveness and convenience of antihypertensive treatments, and governments and healthcare organizations in several countries across the world implementing various initiatives to combat hypertension and reduce the associated disease burden, such as awareness campaigns, public health programs, and subsidies or reimbursement policies, are creating a positive outlook for the market across the globe. Looking forward, the market value is projected to reach US$ 38.0 Billion by 2032, expanding at a CAGR of 2.7% during 2024-2032.


Market Summary:

  • Based on therapeutic class, the market has been segmented into diuretics, ACE inhibitors, calcium channel blockers, beta-adrenergic blockers, vasodilators, and others. Currently, calcium channel blockers holds the largest market share worldwide.
  • On the basis of the type, the market has been segregated into primary hypertension and secondary hypertension. Currently, primary hypertension accounted for the largest market share.
  • Based on the distribution channel, the market has been classified into retail pharmacy, hospital pharmacy, and e-commerce. Presently, hospital pharmacy is holding the largest market share worldwide.
  • On a geographical front, the market has been segmented into Asia Pacific, North America, Europe, Middle East and Africa, and Latin America. Presently, North America is dominating the market across the world.
  • The competitive landscape of the market has also been examined with some of the key players being AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd.


Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Therapeutic Class, Type, Distribution Channel, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Antihypertensive Drugs Market to Reach US$ 38.0 Billion by 2032, Driven by the Increasing Prevalence of Hypertension
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More